Intravenous immune globulin in the therapy of peripartum cardiomyopathy
Biykem Bozkurt, MD*,
Flordeliza S. Villaneuva, MD, FACC ,
Richard Holubkov, PhD ,
Tammy Tokarczyk, RN, BSN ,
René J. Alvarez, Jr., MD ,
Guy A. MacGowan, MB, BCh ,
Srinivas Murali, MD, FACC ,
Warren D. Rosenblum, MD ,
Arthur M. Feldman, MD, PhD, FACC and
Dennis M. McNamara, MD, FACC
* Section of Cardiology, Baylor College of Medicine, VA Medical Center, Houston, Texas, USA
Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

View larger version (24K):
[in a new window]
|
Figure 1 Change in left ventricular ejection fraction (LVEF) during early follow-up. *Improvement significantly greater than with conventional therapy alone, p = 0.042.
|
|
|